Provided by Tiger Trade Technology Pte. Ltd.

TELA Bio, Inc.

0.7859
+0.04796.49%
Volume:50.58K
Turnover:39.66K
Market Cap:35.18M
PE:-1.01
High:0.8000
Open:0.7877
Low:0.7381
Close:0.7380
52wk High:1.87
52wk Low:0.5011
Shares:44.77M
Float Shares:21.52M
Volume Ratio:0.64
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7776
EPS(LYR):-0.8300
ROE:-616.62%
ROA:-33.40%
PB:-2.22
PE(LYR):-0.95

Loading ...

TELA Bio Q1 net loss widens to $12.3 million; revenue rises 3% to $19.1 million

Reuters
·
May 13

TELA Bio Q1 EPS $(0.21) Misses $(0.18) Estimate, Sales $19.059M Beat $18.597M Estimate

Benzinga Earnings
·
May 13

BRIEF-TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million

Reuters
·
May 13

TELA Bio Q1 Income From Operations USD -10.526 Million

THOMSON REUTERS
·
May 13

TELA Bio Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 13

TELA Bio Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
May 09

TELA Bio grants 89,250 restricted stock units to 12 new hires

Reuters
·
May 08

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 08

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Irhythm Technologies (IRTC) and TELA Bio (TELA)

TIPRANKS
·
May 01

TELA Bio Reshapes Board, Appoints New Chairman, Directors

TIPRANKS
·
May 01

TELA Bio sees Q1 revenue about $19 million, above prior $18.5 million view

Reuters
·
May 01

TELA Bio names Joseph Capper board chair in four-director refreshment plan

Reuters
·
May 01

TELA Bio Inc - Prelim Q1 2026 Revenue Approx $19.0 Mln Versus Guidance of $18.5 Mln

THOMSON REUTERS
·
May 01

TELA Bio Inc - Joseph Capper to Be Nominated as Director and Expected to Serve as Chair

THOMSON REUTERS
·
May 01

TELA Bio Inc - Chairman Doug Evans, Kurt Azarbarzin, Vince Burgess, Federica O’brien to Depart Board

THOMSON REUTERS
·
May 01

Press Release: TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

Dow Jones
·
May 01

TELA Bio (TELA) Gets a Buy from Canaccord Genuity

TIPRANKS
·
Apr 24

TELA Bio to Announce First Quarter 2026 Financial Results

GlobeNewswire
·
Apr 22

TELA Bio Is Maintained at Market Outperform by Citizens

Dow Jones
·
Mar 27

Tela Bio price target lowered to $3 from $5 at Citizens

TIPRANKS
·
Mar 27